Fibroblast Growth Factor

Growth Factors
http://faculty.mc3.edu

Delivery of Insulin-Like Growth Factor
Mattia Migliore
http://www.igert.neu.edu/

Cellular Mechanisms of Development
http://faculty.sgc.edu

Fibroblast Growth Factors (FGFs)
http://courses.bio.unc.edu/
http://courses.bio.unc.edu/2

Biology of Cancer
Sumaira Amir Ph.D.
http://www.iccs.edu/

Growth Factor Receptor Signaling
http://www.sbs.utexas.edu

Anti-Cancer Therapy Monoclonal Antibodies
Firouzeh Kamali
http://faculty.smu.edu/

Achondroplasia
http://www.bellarmine.edu

Mechanical Strain and Growth Factors
http://home.utah.edu

Natural History of Achondroplasia
http://www.science.marshall.edu

Endothelial Growth Factor
http://www.chem.uwec.edu

Bone Growth
http://medinfo.ufl.edu

Angiogenesis, Maturation and Microvessel Network Remodeling
Jay B. Hoying, PhD
http://mbi.osu.edu

Extracellular Matrix Based Regulation of a Cytokine Gradient at the Growth Plate
Jonathan Behr, David Berry
http://web.mit.edu

Inhibition of Ethanol Neurotoxicity by Treatment with Growth Factors and Estrogen
Jason A. Zell, M.S., Jeremy R. Montague, Ph.D., Tomas F. Lopez, B.S., and Laura M. Mudd, Ph.D
http://snhs-plin.barry.edu


600 free full text published articles on Fibroblast Growth Factor

1. Bone marrow-derived fibroblast growth factor-2 induces glial cell proliferation in the regenerating peripheral nervous system.
2. Fibroblast Growth Factor Receptor 2 homodimerization rapidly reduces transcription of the pluripotency gene Nanog without dissociation of activating transcription factors.
3. Blocking fibroblast growth factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis.
4. Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial.
5. Fibroblast growth factor 22 is not essential for skin development and repair but plays a role in tumorigenesis.
6. Conversion of a Paracrine Fibroblast Growth Factor into an Endocrine Fibroblast Growth Factor.
7. PI(4,5)P2 Dependent Oligomerization of Fibroblast Growth Factor 2 (FGF2) Triggers the Formation of a Lipidic Membrane Pore Implicated in Unconventional Secretion.
8. Characterization of a Novel Fibroblast Growth Factor 10 (Fgf10) Knock-In Mouse Line to Target Mesenchymal Progenitors during Embryonic Development.
9. Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal cancer.
10. Exercise Increases Serum Fibroblast Growth Factor 21 (FGF21) Levels.
11. Fibroblast Growth Factor 21 (FGF21) inhibits chondrocyte function and Growth Hormone (GH) action directly at the growth plate.
12. Cyclooxygenase-2 and hypoxia-regulated proteins are modulated by basic fibroblast growth factor in acute renal failure.
13. Mutant Soluble Ectodomain of Fibroblast Growth Factor Receptor-2 IIIc Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
14. Immunocytochemical colocalization of fibroblast growth factor-1 with neurotrophin-3 in mouse alveolar macrophages.
15. Therapeutic angiogenesis using basic fibroblast growth factor in combination with a collagen matrix in chronic hindlimb ischemia.
16. Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21.
17. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2.
18. Concentration- and time-dependent response of human gingival fibroblasts to fibroblast growth factor 2 immobilized on titanium dental implants.
19. Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.
20. Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease.
21. Fibroblast growth factor receptor 4 Gly388Arg polymorphism associated with severity of gallstone disease in a Chinese population.
22. Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort.
23. Effect of basic fibroblast growth factor and transforming growth factor β1 on the healing of reconstructed dura by carbon dioxide laser soldering in minipigs.
24. Iron status and fibroblast growth factor-23 in Gambian children.
25. Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma.
26. Dietary moderately oxidized oil induces expression of fibroblast growth factor 21 in the liver of pigs.
27. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
28. Genetic analysis of fibroblast growth factor signaling in the Drosophila eye.
29. Various oscillation patterns of serum fibroblast growth factor 21 concentrations in healthy volunteers.
30. Fibroblast growth factor 21: a novel metabolic regulator.
31. Fibroblast growth factor 22 contributes to the development of retinal nerve terminals in the dorsal lateral geniculate nucleus.
32. Analysis of the fibroblast growth factor system reveals alterations in a mouse model of spinal muscular atrophy.
33. An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: a study protocol.
34. Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3.
35. [The effect of basic fibroblast growth factor on the gene expression of syndecan-4 by human periodontal ligament cell in culture].
36. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma.
37. Molecular networks in FGF signaling: flotillin-1 and cbl-associated protein compete for the binding to fibroblast growth factor receptor substrate 2.
38. Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer.
39. Fibroblast growth factor 21 as a possible endogenous factor inhibits apoptosis in cardiac endothelial cells.
40. The serum level of fibroblast growth factor-23 and calcium-phosphate homeostasis in obese perimenopausal women.
41. Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice.
42. Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma.
43. Fibroblast growth factor 10 upregulates the expression of mucins in rat conjunctival epithelial cells.
44. Effects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus.
45. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
46. A novel fibroblast growth factor receptor 2 (FGFR2) mutation associated with a mild Crouzon syndrome.
47. Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma.
48. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.
49. Fibroblast growth factor 2: good or bad guy in the joint?
50. Intraamygdala infusion of fibroblast growth factor 2 enhances extinction and reduces renewal and reinstatement in adult rats.
51. Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study.
52. FRS2α is essential for the fibroblast growth factor to regulate the mTOR pathway and autophagy in mouse embryonic fibroblasts.
53. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.
54. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.
55. Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3.
56. Fibroblast growth factor 23 predicts left ventricular mass and induces cell adhesion molecule formation.
57. Purification and Refolding of Overexpressed Human Basic Fibroblast Growth Factor in Escherichia coli.
58. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes.
59. Fibroblast growth factor-2 primes human mesenchymal stem cells for enhanced chondrogenesis.
60. Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance.
61. Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis.
62. Methylation of eukaryotic elongation factor 2 induced by basic fibroblast growth factor via mitogen-activated protein kinase.
63. Effect of trehalose coating on basic fibroblast growth factor release from tailor-made bone implants.
64. Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition.
65. A variant of fibroblast growth factor receptor 2 (Fgfr2) regulates left-right asymmetry in zebrafish.
66. Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.
67. Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: a case-control study.
68. Production of mouse fibroblast growth factor 4 in E. coli and its application for isolation and maintenance of mouse trophoblast stem cells in vitro.
69. Thiazolidinediones are potent inducers of fibroblast growth factor 21 expression in the liver.
70. Dedifferentiation of human terminally differentiating keratinocytes into their precursor cells induced by basic fibroblast growth factor.
71. Co-localization of neural cell adhesion molecule and fibroblast growth factor receptor 2 in early embryo development.
72. Plasma intact fibroblast growth factor 23 levels in women with bulimia nervosa: A cross-sectional pilot study.
73. A better anti-diabetic recombinant human fibroblast growth factor 21 (rhFGF21) modified with polyethylene glycol.
74. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
75. Enhanced in vitro refolding of fibroblast growth factor 15 with the assistance of SUMO fusion partner.
76. Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization.
77. A novel requirement for Janus kinases as mediators of drug resistance induced by fibroblast growth factor-2 in human cancer cells.
78. A long term study on the role of exogenous human recombinant basic fibroblast growth factor on the superficial digital flexor tendon healing in rabbits.
79. Fibroblast growth factor signalling controls successive cell behaviours during mesoderm layer formation in Drosophila.
80. Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels.
81. The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination.
82. Senataxin modulates neurite growth through fibroblast growth factor 8 signalling.
83. Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-α agonist treatment.
84. Interferon-α/β and anti-fibroblast growth factor receptor 1 monoclonal antibody suppress hepatic cancer cells in vitro and in vivo.
85. Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease.
86. Identification of novel interaction sites that determine specificity between fibroblast growth factor homologous factors and voltage-gated sodium channels.
87. Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis.
88. Efficient production of human acidic fibroblast growth factor in pea (Pisum sativum L.) plants by agroinfection of germinated seeds.
89. Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma.
90. Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals.
91. Aryl Extensions of Thienopyrimidinones as Fibroblast Growth Factor Receptor 1 Kinase Inhibitors.
92. Tricyclic antidepressant amitriptyline activates fibroblast growth factor receptor signaling in glial cells: involvement in glial cell line-derived neurotrophic factor production.
93. Fibroblast growth factor receptor 3 (FGFR3) is a strong heat shock protein 90 (Hsp90) client: implications for therapeutic manipulation.
94. New insights to fibroblast growth factor 23 in kidney transplant.
95. Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions.
96. Detection of isoform-specific fibroblast growth factor receptors by whole-mount in situ hybridization in early chick embryos.
97. A novel mode of protein kinase inhibition exploiting hydrophobic motifs of autoinhibited kinases: discovery of ATP-independent inhibitors of fibroblast growth factor receptor.
98. Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain.
99. Interaction of ATP with fibroblast growth factor 2: biochemical characterization and consequence for growth factor stability.
100. Normal skin and hypertrophic scar fibroblasts differentially regulate collagen and fibronectin expression as well as mitochondrial membrane potential in response to basic fibroblast growth factor.
101. Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential.
102. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.
103. [Dynamic expression of wnt and fibroblast growth factor ligands in cleft palate induced by retinoic acid].
104. Exogenous fibroblast growth factor 8 rescues development of mouse diastemal vestigial tooth ex vivo.
105. Acid fibroblast growth factor and peripheral nerve grafts regulate Th2 cytokine expression, macrophage activation, polyamine synthesis, and neurotrophin expression in transected rat spinal cords.
106. Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system.
107. Alk5-mediated transforming growth factor β signaling acts upstream of fibroblast growth factor 10 to regulate the proliferation and maintenance of dental epithelial stem cells.
108. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
109. Fibroblast growth factor receptor-3 (FGFR-3) regulates expression of paneth cell lineage-specific genes in intestinal epithelial cells through both TCF4/beta-catenin-dependent and -independent signaling pathways.
110. Effect of basic fibroblast growth factor and cytochrome c peroxidase combination in transgenic mice corneal epithelial healing process after excimer laser photoablation.
111. Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma.
112. [Association between fibroblast growth factor 3 polymorphism and non-syndromic oral clefting].
113. Morphological and functional midbrain phenotypes in Fibroblast Growth Factor 17 mutant mice detected by Mn-enhanced MRI.
114. Identification and characterization of an inhibitory fibroblast growth factor receptor 2 (FGFR2) molecule, up-regulated in an Apert Syndrome mouse model.
115. Toward a novel endogenous anxiolytic factor, fibroblast growth factor 2.
116. Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis.
117. Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging.
118. Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans.
119. Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism.
120. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
121. Comprehensive analysis of fibroblast growth factor receptor expression patterns during chick forelimb development.
122. Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-γ.
123. Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase.
124. Incidence of fibroblast growth factor receptor 3 gene (FGFR3) A248C, S249C, G372C, and T375C mutations in bladder cancer.
125. Conditional transgenic expression of fibroblast growth factor 9 in the adult mouse heart reduces heart failure mortality after myocardial infarction.
126. Expression of angiogenic basic fibroblast growth factor, platelet derived growth factor, thrombospondin-1 and their receptors at the porcine maternal-fetal interface.
127. Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease.
128. Fibroblast growth factor-2 alters the nature of extinction.
129. Fibroblast growth factor-2 promotes in vitro mitral valve interstitial cell repair through transforming growth factor-β/Smad signaling.
130. Short-hairpin RNA silencing of endogenous fibroblast growth factor 2 in rat hippocampus increases anxiety behavior.
131. Fibroblast growth factor-10 promotes cardiomyocyte differentiation from embryonic and induced pluripotent stem cells.
132. Effects of temperature and additives on stability and spectrum of a therapeutic fibroblast growth factor.
133. Effect of basic fibroblast growth factor on cat corneal endothelial cell proliferation.
134. Protein kinase C delta mediates fibroblast growth factor-2-induced interferon-tau expression in bovine trophoblast.
135. Investigating the refolding pathway of human acidic fibroblast growth factor (hFGF-1) from the residual structure(s) obtained by denatured-state hydrogen/deuterium exchange.
136. ATP differentially upregulates fibroblast growth factor 2 and transforming growth factor α in neonatal and adult mice: effect on neuroproliferation.
137. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium.
138. [Effects of dexamethasone and vitamin B12 on expression of fibroblast growth factor 10 and fibroblast growth factor receptor 2b during early palatogenesis].
139. [The effect of basic fibroblast growth factor on the mRNA expression of beta1 integrin subunit by periodontal ligament fibroblasts in culture].
140. The impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF).
141. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice.
142. Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis.
143. Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis.
144. Evaluation of additives required for periodontal disease formulation using basic fibroblast growth factor.
145. Fibroblast growth factor signaling in the developing neuroendocrine hypothalamus.
146. Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model.
147. The extracellular domain of fibroblast growth factor receptor 3 inhibits ligand-independent dimerization.
148. Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism.
149. Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.
150. The healing of full-thickness articular cartilage defects in rabbits: successful results with fibroblast growth factor.
151. Roles of fibroblast growth factor receptors in carcinogenesis.
152. Abnormal hypothalamic oxytocin system in fibroblast growth factor 8-deficient mice.
153. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).
154. Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T.
155. Elevated fibroblast growth factor 23 levels in a newborn with secondary hypoparathyroidism.
156. Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer.
157. Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.
158. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23.
159. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
160. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
161. Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.
162. Induction of an osteocyte-like phenotype by fibroblast growth factor-2.
163. The value of angiogenic therapy with intramyocardial administration of basic fibroblast growth factor to treat severe coronary artery disease.
164. The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism.
165. The effects of exogenous basic fibroblast growth factor on intrasynovial flexor tendon healing in a canine model.
166. Basic fibroblast growth factor activates MEK/ERK cell signaling pathway and stimulates the proliferation of chicken primordial germ cells.
167. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
168. Fibroblast growth factor 10 enhances bovine oocyte maturation and developmental competence in vitro.
169. NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression.
170. Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1.
171. Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding.
172. Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells.
173. Synthesis of N-heteroaroyl aminosaccharide derivatives as fibroblast growth factor 2 signaling modulators.
174. Piwi-like 2 mediates fibroblast growth factor signaling during gastrulation of zebrafish embryo.
175. Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice.
176. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.
177. Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-1.
178. Fibroblast growth factor-10 signals development of von Brunn's nests in the exstrophic bladder.
179. Co-localization and regulation of basic fibroblast growth factor and arginine vasopressin in neuroendocrine cells of the rat and human brain.
180. Evaluation of a method for fibroblast growth factor-23: a novel biomarker of adverse outcomes in patients with renal disease.
181. Novel method of cell-free in vitro synthesis of the human fibroblast growth factor 1 gene.
182. Role of fibroblast growth factor signaling during proepicardium formation in the chick embryo.
183. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.
184. Fibroblast growth factor type 2 signaling is critical for DNA repair in human keratinocyte stem cells.
185. Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts.
186. Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.
187. Change in fibroblast growth factor 2 expression as an early phase radiotherapy-responsive marker in sequential biopsy samples from patients with cervical cancer during fractionated radiotherapy.
188. Fibroblast growth factor: will this hormone be the hemoglobin A1c for managing phosphorus balance in chronic kidney disease?
189. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19).
190. Influence of the fibroblast growth factor receptor 4 expression and the G388R functional polymorphism on Cushing's disease outcome.
191. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
192. Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
193. Early growth response-1 induction by fibroblast growth factor-1 via increase of mitogen-activated protein kinase and inhibition of protein kinase B in hippocampal neurons.
194. Sulfatase modifying factor 1-mediated fibroblast growth factor signaling primes hematopoietic multilineage development.
195. Fibroblast growth factor-2 stimulates the proliferation of mesenchyme-derived progenitor cells from aging mouse and human bone.
196. Neuritogenic and neuroprotective properties of Peptide agonists of the fibroblast growth factor receptor.
197. Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss.
198. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.
199. Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor.
200. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway.
201. Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway.
202. Resveratrol inhibits angiogenic response of cultured endothelial F-2 cells to vascular endothelial growth factor, but not to basic fibroblast growth factor.
203. Ablation of systemic phosphate-regulating gene fibroblast growth factor 23 (Fgf23) compromises the dentoalveolar complex.
204. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
205. The heparan sulfate co-receptor and the concentration of fibroblast growth factor-2 independently elicit different signalling patterns from the fibroblast growth factor receptor.
206. Potential for targeting the fibroblast growth factor receptors in breast cancer.
207. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
208. Bimodal, reciprocal regulation of fibroblast growth factor receptor 1 promoter activity by BTEB1/KLF9 during myogenesis.
209. Compound deficiencies in multiple fibroblast growth factor signalling components differentially impact the murine gonadotrophin-releasing hormone system.
210. An N-, C-terminally truncated basic fibroblast growth factor and LPD (liposome-polycation-DNA) complexes elicits a protective immune response against murine colon carcinoma.
211. 1alpha,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro.
212. Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets/osteomalacia.
213. Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells.
214. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
215. Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan.
216. Association between genetic polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women.
217. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.
218. [Effect of continuous passive motion on basic fibroblast growth factor expression during tendon-bone repair after surgical repair of acute rupture of the supraspinatus tendon in rabbits].
219. Improvement of gait patterns in step-trained, complete spinal cord-transected rats treated with a peripheral nerve graft and acidic fibroblast growth factor.
220. Expression and function of fibroblast growth factor 18 in the ovarian follicle in cattle.
221. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.
222. Kynurenine inhibits fibroblast growth factor 2-mediated expression of crystallins and MIP26 in lens epithelial cells.
223. Guidance of postural motoneurons requires MAPK/ERK signaling downstream of fibroblast growth factor receptor 1.
224. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
225. Viral fibroblast growth factor, matrix metalloproteases, and caspases are associated with enhancing systemic infection by baculoviruses.
226. A common variant in fibroblast growth factor binding protein 1 (FGFBP1) is associated with bone mineral density and influences gene expression in vitro.
227. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
228. NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells.
229. A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist.
230. Fibroblast growth factor and insulin-like growth factor rescue growth cones of sensory neurites from collapse after tetracaine-induced injury.
231. Expression of fibroblast growth factor receptor 3 in the recurrence of non-muscle-invasive urothelial carcinoma of the bladder.
232. Differential fibroblast growth factor 8 (FGF8)-mediated autoregulation of its cognate receptors, Fgfr1 and Fgfr3, in neuronal cell lines.
233. Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer.
234. Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification.
235. Involvement of beta1-integrin up-regulation in basic fibroblast growth factor- and epidermal growth factor-induced proliferation of mouse neuroepithelial cells.
236. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.
237. Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice.
238. Signaling from fibroblast growth factor receptor 2 in immature hematopoietic cells facilitates donor hematopoiesis after intra-bone marrow-bone marrow transplantation.
239. Fibroblast growth factor 2 regulates bone sialoprotein gene transcription in human breast cancer cells.
240. Effects of 6-bromoindirubin-3'-oxime on the maintenance of pluripotency of porcine embryonic germ cells in combination with stem cell factor, leukemia inhibitory factor and fibroblast growth factor.
241. SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.
242. Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis.
243. Caenorhabditis elegans fibroblast growth factor receptor signaling can occur independently of the multi-substrate adaptor FRS2.
244. Fibroblast growth factor 23 mediates the phosphaturic actions of cadmium.
245. Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner.
246. Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.
247. Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events.
248. The heterohexameric complex structure, a component in the non-classical pathway for fibroblast growth factor 1 (FGF1) secretion.
249. Regulation of fibroblast growth factor-2 by an endogenous antisense RNA and by argonaute-2.
250. Cardiac protection by basic fibroblast growth factor from ischemia/reperfusion-induced injury in diabetic rats.
251. Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation.
252. Augmentation of surgical angiogenesis in vascularized bone allotransplants with host-derived a/v bundle implantation, fibroblast growth factor-2, and vascular endothelial growth factor administration.
253. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.
254. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations.
255. Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5.
256. A novel conserved phosphotyrosine motif in the Drosophila fibroblast growth factor signaling adaptor Dof with a redundant role in signal transmission.
257. Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors.
258. A case of Kallmann syndrome carrying a missense mutation in alternatively spliced exon 8A encoding the immunoglobulin-like domain IIIb of fibroblast growth factor receptor 1.
259. Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells.
260. Fibroblast growth factor-2 enhances extinction and reduces renewal of conditioned fear.
261. Discovery of novel fibroblast growth factor receptor 1 kinase inhibitors by structure-based virtual screening.
262. A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation.
263. Incisor degeneration in rats induced by vascular endothelial growth factor/fibroblast growth factor receptor tyrosine kinase inhibition.
264. Fibroblast growth factor receptors control epithelial-mesenchymal interactions necessary for alveolar elastogenesis.
265. Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.
266. F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2.
267. Chondroitin sulfates are required for fibroblast growth factor-2-dependent proliferation and maintenance in neural stem cells and for epidermal growth factor-dependent migration of their progeny.
268. Dynamic expression of axon guidance cues required for optic tract development is controlled by fibroblast growth factor signaling.
269. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
270. Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds.
271. Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study.
272. Churchill and Sip1a repress fibroblast growth factor signaling during zebrafish somitogenesis.
273. Basic fibroblast growth factor regulates persistent ERK oscillations in premalignant but not malignant JB6 cells.
274. A phosphoinositide 3-kinase/phospholipase Cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation.
275. Effect of glypican-1 covalently attached chains on turkey myogenic satellite cell proliferation, differentiation, and fibroblast growth factor 2 responsiveness.
276. The synthetic inhibitor of fibroblast growth factor receptor PD166866 controls negatively the growth of tumor cells in culture.
277. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.
278. Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection.
279. Dendrimer-based tumor cell targeting of fibroblast growth factor-1.
280. Small cytoskeleton-associated molecule, fibroblast growth factor receptor 1 oncogene partner 2/wound inducible transcript-3.0 (FGFR1OP2/wit3.0), facilitates fibroblast-driven wound closure.
281. Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk.
282. Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism.
283. 1-tert-butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a selective tyrosine kinase inhibitor of fibroblast growth factor receptor-3 (FGFR3), inhibits cell proliferation of bladder cancer carrying the FGFR3 gene mutation along with up-regulation of p27/Kip1 and G1/G0 arrest.
284. Neuroplastin-55 binds to and signals through the fibroblast growth factor receptor.
285. Basic fibroblast growth factor elicits formation of interstitial axonal branches via enhanced severing of microtubules.
286. Heparan sulfation-dependent fibroblast growth factor signaling maintains embryonic stem cells primed for differentiation in a heterogeneous state.
287. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
288. Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa.
289. Engineering an improved crystal contact across a solvent-mediated interface of human fibroblast growth factor 1.
290. X-ray structure and biophysical properties of rabbit fibroblast growth factor 1.
291. Fibroblast growth factor 2 positively regulates expression of activating transcription factor 4 in osteoblasts.
292. Fibroblast growth factor 21: from pharmacology to physiology.
293. The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo.
294. Evaluation of Spinal Fusion Using Bone Marrow Derived Mesenchymal Stem Cells with or without Fibroblast Growth Factor-4.
295. Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells.
296. Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.
297. Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells.
298. Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis.
299. Response to carbohydrate and fat refeeding in the expression of genes involved in nutrient partitioning and metabolism: striking effects on fibroblast growth factor-21 induction.
300. Inhibition of caspase-mediated anoikis is critical for basic fibroblast growth factor-sustained culture of human pluripotent stem cells.
301. Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signaling.
302. Progressive interdigital cell death: regulation by the antagonistic interaction between fibroblast growth factor 8 and retinoic acid.
303. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism.
304. Bone formation regulates circulating concentrations of fibroblast growth factor 23.
305. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.
306. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits fibroblast growth factor 10-induced prostatic bud formation in mouse urogenital sinus.
307. N-Glycosylation regulates fibroblast growth factor receptor/EGL-15 activity in Caenorhabditis elegans in vivo.
308. Virion-associated viral fibroblast growth factor stimulates cell motility.
309. Effects of basic fibroblast growth factor on the development of the stem cell properties of human dental pulp cells.
310. Protein engineering of a fibroblast growth factor-1 fusion protein with cell adhesive activity.
311. Fibroblast growth factor 23 and its role in phosphate homeostasis.
312. Expression of fibroblast growth factor binding protein in head and neck cancer.
313. Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression.
314. Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner.
315. Regenerative effects of basic fibroblast growth factor on extracellular matrix production in aged rat vocal folds.
316. Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis.
317. Egr-1 is necessary for fibroblast growth factor-2-induced transcriptional activation of the glial cell line-derived neurotrophic factor in murine astrocytes.
318. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia.
319. Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway.
320. Non-surgical closure of post-pneumonectomy empyema with bronchopleural fistula after open window thoracotomy using basic fibroblast growth factor.
321. An intrinsic quality-control mechanism ensures unconventional secretion of fibroblast growth factor 2 in a folded conformation.
322. Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.
323. Malignant acanthosis nigricans with enhanced expression of fibroblast growth factor receptor 3.
324. Culture effects of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose-derived stromal/stem cell proliferation and adipogenesis.
325. Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism.
326. Analysis of non-canonical fibroblast growth factor receptor 1 (FGFR1) interaction reveals regulatory and activating domains of neurofascin.
327. Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release.
328. Suppression of fibroblast growth factor-2 expression: possible mechanism underlying methylmercury-induced inhibition of the repair of wounded monolayers of cultured human brain microvascular endothelial cells.
329. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer.
330. [Effect of basic fibroblast growth factor on the gene expression of epidermal growth factor receptor by periodontal ligament cells in culture].
331. Epicardium and myocardium separate from a common precursor pool by crosstalk between bone morphogenetic protein- and fibroblast growth factor-signaling pathways.
332. Molecular pathology of the fibroblast growth factor family.
333. Fibroblast growth factor-2 regulates the stability of nuclear bodies.
334. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.
335. Inactivation of fibroblast growth factor receptor signaling in myelinating glial cells results in significant loss of adult spiral ganglion neurons accompanied by age-related hearing impairment.
336. Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.
337. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.
338. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model.
339. Fibroblast growth factor 2: A new key player in osteoarthritis.
340. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis.
341. Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix.
342. The p107/E2F pathway regulates fibroblast growth factor 2 responsiveness in neural precursor cells.
343. Fibroblast growth factor 1 induced during myogenesis by a transcription-translation coupling mechanism.
344. Fibroblast growth factor (FGF) gene expression in the developing cerebellum suggests multiple roles for FGF signaling during cerebellar morphogenesis and development.
345. Regulation and action of fibroblast growth factor 17 in bovine follicles.
346. Expression of hepatocyte growth factor and basic fibroblast growth factor as prognostic indicators in gastric cancer.
347. Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man.
348. Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus.
349. Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma.
350. Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.
351. The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer.
352. Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice.
353. Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer.
354. Beta-tricalcium phosphate and basic fibroblast growth factor combination enhances periodontal regeneration in intrabony defects in dogs.
355. Nonviral delivery of basic fibroblast growth factor gene to bone marrow stromal cells.
356. Fibroblast growth factor-2 overexpression in transplanted neural progenitors promotes perivascular cluster formation with a neurogenic potential.
357. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.
358. Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer.
359. [Fibroblast Growth Factor 23-Klotho: a new axis of phosphate balance control].
360. Fibroblast growth factor 2 reactivates G1 checkpoint in SK-N-MC cells via regulation of p21, inhibitor of differentiation genes (Id1-3), and epithelium-mesenchyme transition-like events.
361. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity.
362. Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer.
363. Vascular regeneration by repeated infusions of basic fibroblast growth factor in a rabbit model of hind-limb ischemia.
364. Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization.
365. A distinct role for secreted fibroblast growth factor-binding proteins in development.
366. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
367. KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization.
368. Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3).
369. Fibroblast growth factor receptor-3 regulates Paneth cell lineage allocation and accrual of epithelial stem cells during murine intestinal development.
370. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels.
371. Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.
372. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
373. Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis.
374. Basic fibroblast growth factor causes urinary bladder overactivity through gap junction generation in the smooth muscle.
375. Actions of fibroblast growth factor-8 in bone cells in vitro.
376. Expression and possible role of fibroblast growth factor family members in porcine antral follicles during final maturation.
377. Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model.
378. Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells.
379. Fibroblast growth factor 18 gives growth and directional cues to airway cartilage.
380. Connexin43 potentiates osteoblast responsiveness to fibroblast growth factor 2 via a protein kinase C-delta/Runx2-dependent mechanism.
381. FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression.
382. Characterisation of the fibroblast growth factor dependent transcriptome in early development.
383. Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus.
384. Identification of novel fibroblast growth factor receptor 3 gene mutations in actinic cheilitis and squamous cell carcinoma of the lip.
385. Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin.
386. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.
387. Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop.
388. [Construction of eukaryotic expression vectors of basic fibroblast growth factor and transfection in rabbit bone marrow stromal cells].
389. Trophoblast stem cell maintenance by fibroblast growth factor 4 requires MEKK4 activation of Jun N-terminal kinase.
390. A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells.
391. Role of basic fibroblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts.
392. Fibroblast growth factor 2-stimulated proliferation is lower in muscle precursor cells from old rats.
393. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization.
394. Fibroblast growth factor receptor-1 (FGFR1) nuclear dynamics reveal a novel mechanism in transcription control.
395. The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts.
396. Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival.
397. Skeletal effects of fibroblast growth factor mimetic (F2A) in ovariectomized rats.
398. Resistance to chemotherapy is associated with fibroblast growth factor receptor 4 up-regulation.
399. Fibroblast growth factor expression during skeletal fracture healing in mice.
400. Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.
401. Acute systemic fibroblast growth factor-2 enhances long-term extinction of fear and reduces reinstatement in rats.
402. Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation.
403. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.
404. Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity.
405. Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells.
406. Basic fibroblast growth factor delivery enhances adrenal cortical cellular regeneration.
407. Roles of cyclooxygenase-2 in microvascular endothelial cell proliferation induced by basic fibroblast growth factor.
408. Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis.
409. The strong dimerization of the transmembrane domain of the fibroblast growth factor receptor (FGFR) is modulated by C-terminal juxtamembrane residues.
410. Fibroblast growth factor-2 deficiency affects hippocampal spine morphology, but not hippocampal catecholaminergic or cholinergic innervation.
411. Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.
412. Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma.
413. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling.
414. Massive T-lymphocyte infiltration into the host stroma is essential for fibroblast growth factor-2-promoted growth and metastasis of mammary tumors via neovascular stability.
415. Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.
416. In situ loading of basic fibroblast growth factor within porous silica nanoparticles for a prolonged release.
417. Gene targeted ablation of high molecular weight fibroblast growth factor-2.
418. Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform.
419. An intronic alteration of the fibroblast growth factor 10 gene causing ALSG-(aplasia of lacrimal and salivary glands) syndrome.
420. Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury.
421. Fibroblast growth factor 9 signaling inhibits airway smooth muscle differentiation in mouse lung.
422. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
423. Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice.
424. Exported 18-kDa isoform of fibroblast growth factor-2 is a critical determinant of bone mass in mice.
425. Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes.
426. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.
427. Nuclear factor Y is required for basal activation and chromatin accessibility of fibroblast growth factor receptor 2 promoter in osteoblast-like cells.
428. S100beta and fibroblast growth factor-2 are present in cultured Schwann cells and may exert paracrine actions on the peripheral nerve injury.
429. In vitro and in vivo evidence for stimulation of bone resorption by an EP4 receptor agonist and basic fibroblast growth factor: Implications for their efficacy as bone anabolic agents.
430. Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis.
431. Fibroblast growth factor receptor-induced phosphorylation of ephrinB1 modulates its interaction with Dishevelled.
432. Roles of extracellular signal-regulated kinase 1/2 on the suppression of myostatin gene expression induced by basic fibroblast growth factor.
433. Spatiotemporal regulation of fibroblast growth factor signal blocking for endoderm formation in Xenopus laevis.
434. Growth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20.
435. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
436. Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells.
437. Fibroblast growth factor inhibits interferon gamma-STAT1 and interleukin 6-STAT3 signaling in chondrocytes.
438. Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes.
439. Canine fibroblast growth factor receptor 3 sequence is conserved across dogs of divergent skeletal size.
440. Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia.
441. Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.
442. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.
443. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.
444. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
445. Indirect recruitment of the signalling adaptor Shc to the fibroblast growth factor receptor 2 (FGFR2).
446. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.
447. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
448. Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.
449. Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2.
450. Generation of spinal motor neurons from human fetal brain-derived neural stem cells: role of basic fibroblast growth factor.
451. Secreted proteoglycans directly mediate human embryonic stem cell-basic fibroblast growth factor 2 interactions critical for proliferation.
452. [Effects of small interfering RNA targeting basic fibroblast growth factor on proliferation and apoptosis of glioma cell line U251].
453. Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cells.
454. Novel cross-talk between three cardiovascular regulators: thrombin cleavage fragment of Jagged1 induces fibroblast growth factor 1 expression and release.
455. [The effect of basic fibroblast growth factor on the gene expression of decorin by periodontal ligament fibroblasts in culture].
456. Induction of fibroblast growth factor 10 (FGF10) in the ileal crypt epithelium after massive small bowel resection suggests a role for FGF10 in gut adaptation.
457. Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.
458. IFATS collection: Fibroblast growth factor-2-induced hepatocyte growth factor secretion by adipose-derived stromal cells inhibits postinjury fibrogenesis through a c-Jun N-terminal kinase-dependent mechanism.
459. Fibroblast growth factor-regulated palmitoylation of the neural cell adhesion molecule determines neuronal morphogenesis.
460. Sustained release of prostaglandin E1 potentiates the impaired therapeutic angiogenesis by basic fibroblast growth factor in diabetic murine hindlimb ischemia.
461. Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.
462. The effect of fibroblast growth factor 2 on the in vitro expression of syndecan-4 and glypican-1 in turkey satellite cells.
463. Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis.
464. Enrichment and differentiation of human germ-like cells mediated by feeder cells and basic fibroblast growth factor signaling.
465. Biologically active fibroblast growth factor 1 tagged with various epitopes.
466. Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the basic fibroblast growth factor signaling cascade and reducing extracellular regulated kinase 1/2-dependent cyclin E expression.
467. Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3).
468. Role of fibroblast growth factor 8 (FGF8) in animal models of osteoarthritis.
469. Fibroblast growth factor 21 corrects obesity in mice.
470. Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling.
471. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
472. Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons.
473. Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A.
474. Fibroblast growth factor 2 restrains Ras-driven proliferation of malignant cells by triggering RhoA-mediated senescence.
475. Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.
476. Role of fibroblast growth factor receptor 2 in kidney mesenchyme.
477. Up-regulation of brain-derived neurotrophic factor by application of fibroblast growth factor-2 to the cut optic nerve is important for long-term survival of retinal ganglion cells.
478. Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions.
479. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury.
480. Basic fibroblast growth factor impact on retinoblastoma progression and survival.
481. [Effects of basic fibroblast growth factor on the proliferation of human salivary adenoid cystic carcinoma cell line ACC-2 and extracellular signal-regulated kinase, Cyclin D1, p2waf/cip1 signaling pathway].
482. Human infrapatellar fat pad-derived stem cells express the pericyte marker 3G5 and show enhanced chondrogenesis after expansion in fibroblast growth factor-2.
483. Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial.
484. Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling.
485. Hypochondroplasia and Acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?
486. hnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc.
487. Fibroblast growth factor 8 signaling through fibroblast growth factor receptor 1 is required for the emergence of gonadotropin-releasing hormone neurons.
488. Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis.
489. Endothelial function of von Hippel-Lindau tumor suppressor gene: control of fibroblast growth factor receptor signaling.
490. Platelet-derived growth factor receptor regulates salivary gland morphogenesis via fibroblast growth factor expression.
491. YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor.
492. A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer.
493. Protein phosphatase 3 differentially modulates vascular endothelial growth factor- and fibroblast growth factor 2-stimulated cell proliferation and signaling in ovine fetoplacental artery endothelial cells.
494. The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity.
495. Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts.
496. Graded hedgehog and fibroblast growth factor signaling independently regulate pituitary cell fates and help establish the pars distalis and pars intermedia of the zebrafish adenohypophysis.
497. Involvement of acidic fibroblast growth factor in spinal cord injury repair processes revealed by a proteomics approach.
498. Ubiquitination of fibroblast growth factor receptor 1 is required for its intracellular sorting but not for its endocytosis.
499. The fibroblast growth factor 2 gene is associated with embryonic mortality in cattle.
500. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.
501. Fibroblast growth factor receptor signaling is essential for lens fiber cell differentiation.
502. Elevated fibroblast growth factor-2 increases tumor necrosis factor-alpha induced endothelial cell death in high glucose.
503. Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2.
504. Action of fibroblast growth factor-2 on the intervertebral disc.
505. Mutagenesis of the crystal contact of acidic fibroblast growth factor.
506. Plasma intact fibroblast growth factor 23 levels in women with anorexia nervosa.
507. Phosphorylation of fibroblast growth factor (FGF) receptor 1 at Ser777 by p38 mitogen-activated protein kinase regulates translocation of exogenous FGF1 to the cytosol and nucleus.
508. Fibroblast growth factor 2 enhances striatal and nigral neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
509. Cell cycle regulation of astrocytes by extracellular nucleotides and fibroblast growth factor-2.
510. Effects of interleukin-1alpha on the production and release of basic fibroblast growth factor in cultured nifedipine-reactive gingival fibroblasts.
511. Inhibition of fibroblast growth factor 2-induced apoptosis involves survivin expression, protein kinase C alpha activation and subcellular translocation of Smac in human small cell lung cancer cells.
512. Cross-talk between fibroblast growth factor and bone morphogenetic proteins regulates gap junction-mediated intercellular communication in lens cells.
513. Fibroblast growth factor regulation of neovascularization.
514. Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.
515. Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23.
516. P70 S6 kinase negatively regulates fibroblast growth factor 2-stimulated interleukin-6 synthesis in osteoblasts: function at a point downstream from protein kinase C.
517. Effect of basic fibroblast growth factor on the proliferation, migration and phenotypic modulation of airway smooth muscle cells.
518. Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3.
519. Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells.
520. Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis.
521. Endothelial cell migration in stable gradients of vascular endothelial growth factor A and fibroblast growth factor 2: effects on chemotaxis and chemokinesis.
522. [Fibroblast growth factor 1 gene and essential hypertension--from the chromosomal region linked to blood pressure to renal glomerulus].
523. Fibroblast growth factor 2 maintains the neurogenic capacity of embryonic neural progenitor cells in vitro but changes their neuronal subtype specification.
524. Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis.
525. Fibroblast growth factor receptor 2 phosphorylation on serine 779 couples to 14-3-3 and regulates cell survival and proliferation.
526. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
527. Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab--an Eastern Cooperative Oncology Group Study.
528. Sporadic adult-onset hypophosphatemic osteomalacia caused by excessive action of fibroblast growth factor 23.
529. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
530. Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer.
531. A light scattering study of the interaction of fibroblast growth factor (FGF) with its receptor.
532. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation.
533. Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling.
534. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.
535. 6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture.
536. Interaction between ERK and GSK3beta mediates basic fibroblast growth factor-induced apoptosis in SK-N-MC neuroblastoma cells.
537. Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations.
538. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
539. Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells.
540. Neurobin/TMPRSS11c, a novel type II transmembrane serine protease that cleaves fibroblast growth factor-2 in vitro.
541. Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction.
542. Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal.
543. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
544. Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesis.
545. Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1.
546. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
547. Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.
548. Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur.
549. The fibroblast growth factor system is downregulated following social defeat.
550. Non-canonical fibroblast growth factor signalling in angiogenesis.
551. Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor.
552. Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1.
553. Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.
554. S100A13-lipid interactions-role in the non-classical release of the acidic fibroblast growth factor.
555. Chemoradiation-induced expression of fibroblast growth factor-2 and laminin in patients with cervical cancer.
556. Src kinase modulates the activation, transport and signalling dynamics of fibroblast growth factor receptors.
557. Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-kappaB.
558. Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes.
559. Fibroblast growth factor and epidermal growth factor differently affect differentiation of murine retinal stem cells in vitro.
560. Electronegative LDL impairs vascular endothelial cell integrity in diabetes by disrupting fibroblast growth factor 2 (FGF2) autoregulation.
561. Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes.
562. Fibroblast growth factor controls the timing of Scl, Lmo2, and Runx1 expression during embryonic blood development.
563. Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation.
564. The effect of fibroblast growth factor-2 on autologous osteochondral transplantation.
565. Fibroblast growth factor receptor 2 regulates proliferation and Sertoli differentiation during male sex determination.
566. Effects of basic fibroblast growth factor on density and morphology of fibroblasts grown on root surfaces with or without conditioning with tetracycline or EDTA.
567. Fibroblast growth factor receptor-1 signaling in pancreatic islet beta-cells is modulated by the extracellular matrix.
568. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.
569. Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.
570. Fibroblast growth factor 1 gene and hypertension: from the quantitative trait locus to positional analysis.
571. Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor.
572. Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation.
573. Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function.
574. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.
575. Intracoronary administration of AdvFGF-5 (fibroblast growth factor-5) ameliorates left ventricular dysfunction and prevents myocyte loss in swine with developing collaterals and ischemic cardiomyopathy.
576. Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice.
577. Four independent mutations in the feline fibroblast growth factor 5 gene determine the long-haired phenotype in domestic cats.
578. Fibroblast growth factor-binding protein and N-deacetylase/N-sulfotransferase-1 expression in type II cells is modulated by heparin and extracellular matrix.
579. Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone: identification of a thyroid hormone response element in the murine Fgfr1 promoter.
580. Effect of basic fibroblast growth factor (bFGF) on the treatment of exposure of the orbital implants.
581. Basic fibroblast growth factor activates the MAPK and NFkappaB pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes.
582. Co-receptor requirements for fibroblast growth factor-19 signaling.
583. Diabetes does not influence oral oncogenesis through fibroblast growth factor receptors.
584. The effect of glypican-1 glycosaminoglycan chains on turkey myogenic satellite cell proliferation, differentiation, and fibroblast growth factor 2 responsiveness.
585. Regulation of ephexin1, a guanine nucleotide exchange factor of Rho family GTPases, by fibroblast growth factor receptor-mediated tyrosine phosphorylation.
586. The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fibroblast growth factor receptor 2-IIIb through histone H3 modifications in thyroid cancer.
587. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro.
588. Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain.
589. Lacrimo-auriculo-dento-digital syndrome is caused by reduced activity of the fibroblast growth factor 10 (FGF10)-FGF receptor 2 signaling pathway.
590. Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels.
591. Sustained-release form of basic fibroblast growth factor prevents catheter-related bacterial invasion in mice.
592. [Effect of gradually induced occlusal disorders on the expression of basic fibroblast growth factor of condylar cartilage in rat].
593. Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease.
594. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
595. A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study.
596. Basic fibroblast growth factor modulates proliferation and collagen expression in urinary bladder smooth muscle cells.
597. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
598. Development of new drug delivery system for implant bone augmentation using a basic fibroblast growth factor-gelatin hydrogel complex.
599. A nuclear export sequence located on a beta-strand in fibroblast growth factor-1.
600. Unconventional secretion: an extracellular trap for export of fibroblast growth factor 2.